eXIthera: FDA Clearance to Start Phase 2a Trial of EP-7041 in Severe COVID-19 – CBI
Homepage /  Press Release /  eXIthera: FDA Clearance to Start Phase 2a Trial of EP-7041 in Severe COVID-19

Press Release

eXIthera: FDA Clearance to Start Phase 2a Trial of EP-7041 in Severe COVID-19